LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New 3D App Provides More Accurate Cancer Diagnosis

By LabMedica International staff writers
Posted on 16 Oct 2017
Image: Three-dimensional images showing the complex vascular system in ovarian cancer (left) and bladder cancer (right). Thick vessels are colored red, thin vessels colored blue (Photo courtesy of Nobuyuki Tanaka / Karolinska Institutet).
Image: Three-dimensional images showing the complex vascular system in ovarian cancer (left) and bladder cancer (right). Thick vessels are colored red, thin vessels colored blue (Photo courtesy of Nobuyuki Tanaka / Karolinska Institutet).
With further development of light-sheet microscopy based 3D imaging, researchers were able to examine tumor biopsy tissue in more detail than current 2D methods, resulting in improved intratumoral heterogeneity phenotyping and diagnosis of solid tumors.

Vast numbers of tumor tissue samples are examined by pathologists around the world, whose pronouncements inform the treatment patients are given. Mistakes can result in more suffering and sometimes death. Current pathological examination methods for assessing tumors use two-dimensional (2D) light microscopy, which can cause a major information gap in studying 3D objects.

“To be sure, the tumors can be divided into sections for individual study, but 3D structures such as the blood and lymph systems are very hard to study in this way,” said study lead investigator Per Uhlén, professor at Karolinska Institutet (Solna, Stockholm, Sweden). To better study human tumor tissue, the researchers applied an imaging technique, currently being used in basic research, that involves making the tissue transparent (clearing) and then reproducing it in 3D in a light-sheet microscope. For example, upon labeling with specific antibodies, certain proteins can be analyzed in more detail.

“Light-sheet microscopy has been used in basic research for a while, but it is only in recent years that it’s been refined so much that it can be used practically in hospitals,” said Prof. Uhlén, “It was an unforgettable experience to look inside a tumor from a patient for the first time.”

Working with clinicians from Karolinska University Hospital, the researchers were able to study stored samples from patients with bladder cancer and then by 3D reproduction of, amongst other structures, the blood system feeding the tumors, they could find more information about how aggressive the tumors are. The new technique also enabled more accurate diagnosis of muscle-invasive tumors, which can be missed with 2D methods.

“We’ve also studied other cancer types and judge that the method has considerable potential in the clinical diagnosis of all forms of solid tumors, especially cases that are difficult to diagnose,” said Prof. Uhlén.

The light-sheet microscope used for the study is one of only a few in Sweden and is housed at the core facility CLICK – the Center for Live Imaging of Cells at Karolinska Institutet.

The study, by Tanaka N et al, was published October 2, 2017, in the journal Nature Biomedical Engineering.

Related Links:
Karolinska Institutet

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Automatic CLIA Analyzer
Shine i9000

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more